Journal
CELL
Volume 136, Issue 1, Pages 26-36Publisher
CELL PRESS
DOI: 10.1016/j.cell.2008.12.027
Keywords
-
Categories
Funding
- National Institutes of Health
- European Union, through MUGEN
- Cancer Research Institute
- Joint Program in Hematology and Transfusion Medicine at Harvard Medical School
Ask authors/readers for more resources
MicroRNA (miRNA) control has emerged as a critical regulatory principle in the mammalian immune system. Genetic ablation of the miRNA machinery, as well as loss or deregulation of certain individual miRNAs, severely compromises immune development and response and can lead to immune disorders like autoimmunity and cancer. Although individual miRNAs modulate protein output from hundreds of target genes, they may impact physiological processes by regulating the concentrations of just a few key cellular proteins that may be components of a single or of functionally interrelated pathways in a given cellular context.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available